Clinical Genome Sequencing (CLIA / CAP)
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
To support pre-clinical and clinical regulatory submissions, GENEWIZ has established Good Laboratory Practices (GLP) and Clinical Laboratory Improvement Amendments (CLIA)-compliant workflows.